A telehealth tool developed at UC Davis Health can reliably assess infant development as well as gold-standard in-person methods, according to a new study.

The findings, published recently in the Journal of Clinical Child and Adolescent Psychology, validate the tool known as TEDI, or Telehealth Evaluation of Development for Infants. The tool could help expand access to developmental monitoring and support for infants with an increased likelihood of autism, ADHD and other developmental conditions, especially in rural or underserved communities.
Addressing a data gap
During the COVID-19 pandemic, many researchers pivoted to telehealth to assess child development. But very few studies have compared data gathered at home with data gathered from an in-person lab setting. The new study is one of the first to do that, by analyzing both methods in the same group of infants.
“We found that overall, measures collected via telehealth in families’ homes were very similar to those from traditional laboratory assessments,” said Meagan Talbott, who developed TEDI and is the lead author on the paper. Talbott is an associate professor in the Department of Psychiatry and Behavioral Sciences and a UC Davis MIND Institute faculty member.
“This supports the idea that telehealth can be a valid and reliable way to conduct early developmental assessments, so families do not always need to travel to a clinic or research center,” she explained.
Several studies, including a 2025 paper from MIND Institute researchers, have compared in-person and remote assessments for autism diagnosis. Generally, they’ve found that remote telehealth-based autism diagnosis is reliable, but in-person diagnosis is more appropriate for some families.
What sets TEDI apart is its focus on infancy, before most children are old enough to receive a diagnosis. The tool was designed to capture changes in infants who are more likely to have developmental differences, such as those with an autistic sibling or a parent with ADHD.